Skip to main content
  • Home
  •  Advances in Imaging: Optimising MR and CT in Daily Practice

Advances in Imaging: Optimising MR and CT in Daily Practice

Topic:
  • Prevention

Available Credit:

  • 2.00 EBAC

Course Published On:

Course Expiry Date:

Advances in Imaging: Optimising MR and CT in Daily Practice
No ratings

Overview

Currently, despite guidelines acknowledging the utility of imaging for pre-procedural planning, specific guidance is lacking.
 

This faculty-led, educational series has been devised, in conjunction with course director Dr Andrew Arai, to address that need and to provide practical guidance for pre-procedural imaging during the planning phases of atherosclerosis and ventricular arrythmia management.
 

For both disease states we provide a broad overview of the use of imaging through peer-to-peer discussion with therapy area experts; specific imaging applications are explored through faculty presented case reviews.

Support Statement

This programme is supported by an unrestricted educational grant from Circle Cardiovascular Imaging. The scientific programme has not been influenced in any way by the sponsor.

Disclosure

In compliance with ACCREDITED (EBAC / EACCME / ISCP) guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. 

 

The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities. 

Terms & Conditions

Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable. 

 

The session, ‘Advances In Imaging: Optimising MR and CT in Daily Practice’ is accredited by the European Board for Accreditation in Cardiology (EBAC) for 2 hours of external CME credits. 

 

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS). 

 

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.

Instructions to Participants

There is no fee for taking part in this online learning activity. 

 

Activities are designed to be completed within 2 hours and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame. 

 

To complete the course and claim certification participants must: 

 

  • Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions. 

 

  • Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.

Target Audience

  • Electrophysiologists, Imaging Specialists, Cardiologists and Interventional Cardiologists.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Interpret existing clinical and meta data for use of pre-procedural, image-aided ablation in ventricular arrhythmias
  • Identify where pre-procedural imaging may complement the current ablation workflow in ventricular arrhythmias
  • Recall the clinical benefits of quantitative, MRI-based approaches to evaluate ischaemia
  • Apply quantitative CMR imaging to complement existing procedural workflows in revascularisation procedures

Module

Title

Duration

Speakers

Ventricular Arrhythmias and Ablation Pre-procedural imaging in ventricular arrhythmias: A peer-to-peer discussion 29mins 9 seconds Antonio Berruezo (Barcelona, Spain) Saman Nazarian (Philadelphia, USA)
Ventricular Arrhythmias and Ablation Pre-Procedural Planning in VT Post-MI: Case review 18mins 55seconds Saman Nazarian (Philadelphia, USA)
Quantitative CMR: A Case Review of its Diagnostic Utility in CAD Case 1: A 54 year old with exertional angina; two risk factors for CAD 11mins 38seconds Andrew Arai (Bethesda, USA)
Quantitative CMR: A Case Review of its Diagnostic Utility in CAD Cases 2 and 3: A 42 year old healthy volunteer; no family history or risk factors for CAD, and a 68 year old male with history of atypical chest discomfort; one risk factor for CAD 6mins 48seconds Andrew Arai (Bethesda, USA)
Looking to the Future: Quantitative vs Qualitative Myocardial Perfusion PODCAST Introduction and Learning Objectives 2mins 10seconds Andrew Arai (Bethesda, USA) Chiara Bucciarelli-Ducci (London, UK)
Looking to the Future: Quantitative vs Qualitative Myocardial Perfusion PODCAST What does the Literature Say? 8mins 32seconds Andrew Arai (Bethesda, USA) Chiara Bucciarelli-Ducci (London, UK)
Looking to the Future: Quantitative vs Qualitative Myocardial Perfusion PODCAST Qualitative or Quantitative? 8mins 44seconds Andrew Arai (Bethesda, USA) Chiara Bucciarelli-Ducci (London, UK)
Looking to the Future: Quantitative vs Qualitative Myocardial Perfusion PODCAST AI and its Impact on CMR 8mins 16seconds Andrew Arai (Bethesda, USA) Chiara Bucciarelli-Ducci (London, UK)
Looking to the Future: Quantitative vs Qualitative Myocardial Perfusion PODCAST International Guidelines – What Do They Say? 5mins 35seconds Andrew Arai (Bethesda, USA) Chiara Bucciarelli-Ducci (London, UK)
Ventricular Arrhythmias and Ablation.

Pre-procedural imaging in ventricular arrhythmias: A peer-to-peer discussion

Duration: 29mins 9 seconds

Speakers: Antonio Berruezo (Barcelona, Spain) Saman Nazarian (Philadelphia, USA)

Ventricular Arrhythmias and Ablation.

Pre-Procedural Planning in VT Post-MI: Case review

Duration: 18mins 55seconds

Speakers: Saman Nazarian (Philadelphia, USA)

Quantitative CMR: A Case Review of its Diagnostic Utility in CAD.

Case 1: A 54 year old with exertional angina; two risk factors for CAD

Duration: 11mins 38seconds

Speakers: Andrew Arai (Bethesda, USA)

Quantitative CMR: A Case Review of its Diagnostic Utility in CAD.

Cases 2 and 3: A 42 year old healthy volunteer; no family history or risk factors for CAD, and a 68 year old male with history of atypical chest discomfort; one risk factor for CAD

Duration: 6mins 48seconds

Speakers: Andrew Arai (Bethesda, USA)

Looking to the Future: Quantitative vs Qualitative Myocardial Perfusion PODCAST.

Introduction and Learning Objectives

Duration: 2mins 10seconds

Speakers: Andrew Arai (Bethesda, USA) Chiara Bucciarelli-Ducci (London, UK)

Looking to the Future: Quantitative vs Qualitative Myocardial Perfusion PODCAST.

What does the Literature Say?

Duration: 8mins 32seconds

Speakers: Andrew Arai (Bethesda, USA) Chiara Bucciarelli-Ducci (London, UK)

Looking to the Future: Quantitative vs Qualitative Myocardial Perfusion PODCAST.

Qualitative or Quantitative?

Duration: 8mins 44seconds

Speakers: Andrew Arai (Bethesda, USA) Chiara Bucciarelli-Ducci (London, UK)

Looking to the Future: Quantitative vs Qualitative Myocardial Perfusion PODCAST.

AI and its Impact on CMR

Duration: 8mins 16seconds

Speakers: Andrew Arai (Bethesda, USA) Chiara Bucciarelli-Ducci (London, UK)

Looking to the Future: Quantitative vs Qualitative Myocardial Perfusion PODCAST.

International Guidelines – What Do They Say?

Duration: 5mins 35seconds

Speakers: Andrew Arai (Bethesda, USA) Chiara Bucciarelli-Ducci (London, UK)

Course Director

Andrew Arai

Dr Andrew Arai is a consultant in cardiovascular magnetic resonance imaging and a Past President of the Society for Cardiovascular Magnetic Resonance.

View full profile

Speaker

Antonio Berruezo

Teknon Medical Center, Barcelona, Spain

Dr Berruezo is Head of the Arrhythmia Department and Director or Research and Innovation at the Heart Ins

View full profile

Saman Nazarian

University of Pennsylvania Perelman School of Medicine

Dr Nazarian obtained a Doctorate in Medicine from Stanford University and PhD in Clinical Epidemiology from the Johns Hopkins Bloomberg School of Public Health.

View full profile
2.00 EBAC

Related Courses

Hyperkalaemia in Cardiorenal Disease – A Case Based Discussion
  • Not accredited

Learning objectives

  • Explain the relationship between sub-optimal RAASi therapy and poor cardio-renal outcomes
  • Identify patients who would benefit from anti-hyperkalaemia medications
  • Select appropriate anti-hyperkalaemia treatments across a range of patient profiles
  • Adopt anti-hyperkalaemia medications as an approach to prolong optimal RAASi therapy
  • Summarise current guideline recommendations on the use of potassium binding agents
See more
Examining a Complex Heart Failure Case
  • 1.00 EBAC

Learning objectives

  • Identify individuals likely to have HFpEF from initial presentation
  • Refer suspected individuals for specialist assessment
  • Initiate GDMT for HF as soon as patients are stable 
  • Initiate GDMT in HF regardless of EF and phenotype
  • Initiate shared decision-making on complex HF patients with other members of the multidisciplinary team including cardiologists, GPs, nephrologists and diabetologists
See more
CVD and Type 2 Diabetes: Navigating Therapeutic Boundaries in GLP-1 RA Use
  • 2.00 EBAC

Learning objectives

  • Describe the burden of ASCVD in type 2 diabetes
  • Assign risk of future CV events to individuals with type 2 diabetes
  • Identify appropriate patients for GLP-1 RA therapy based on clinical trial outcome data to reduce ASCVD risk
  • Recall trial data of anti-diabetes medications that reduce ASCVD risk
  • Recall the pleiotropic effects of GLP-1 RAs and how these may impact CV outcomes
  • Describe how early adoption of anti-diabetes therapies with proven CV benefit can positively influence QOL
  • Adopt anti-diabetic therapies with proven ASCVD benefit
See more
Obstructive Hypertrophic Cardiomyopathy: Getting It Right First Time
  • 1.00 EBAC

Learning objectives

  • Recall the general approach to diagnosis and stratification of HCM according to the latest guidelines and expert opinion
  • Apply advanced echocardiographic methodologies to equivocal HCM diagnoses
  • Select appropriate imaging modalities to facilitate accurate risk stratification
  • Stratify patients based on specific risk features and disease severity
  • Choose suitable treatment modalities for patients based on specific disease features and severity
See more